AR061262A1 - Metodo para tratar trastornos respiratorios uso de un antibiotico enla fabricacion de un aerosol y composicion de antibiotico en aerosol - Google Patents

Metodo para tratar trastornos respiratorios uso de un antibiotico enla fabricacion de un aerosol y composicion de antibiotico en aerosol

Info

Publication number
AR061262A1
AR061262A1 ARP070102453A ARP070102453A AR061262A1 AR 061262 A1 AR061262 A1 AR 061262A1 AR P070102453 A ARP070102453 A AR P070102453A AR P070102453 A ARP070102453 A AR P070102453A AR 061262 A1 AR061262 A1 AR 061262A1
Authority
AR
Argentina
Prior art keywords
aerosol
antibiotic
respiratory disorders
manufacture
treatment
Prior art date
Application number
ARP070102453A
Other languages
English (en)
Inventor
Hanumantharao Tatapudy
Syed M Shah
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR061262A1 publication Critical patent/AR061262A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un método para tratar trastorno respiratorios que comprenden administrar un antibiotico en aerosol a un mamífero por vía de un sistema de suministro de droga en aerosol, caracterizado porque el sistema de suministro de drogas en aerosol produce un tamano de partícula en aerosol de 1 a 3 micrometros para al menos 90% de las partículas, y porque el antibiotico comprende ZOSYN, Piperacilina, Tazobactam o TYGACIL.
ARP070102453A 2006-06-07 2007-06-07 Metodo para tratar trastornos respiratorios uso de un antibiotico enla fabricacion de un aerosol y composicion de antibiotico en aerosol AR061262A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81167206P 2006-06-07 2006-06-07

Publications (1)

Publication Number Publication Date
AR061262A1 true AR061262A1 (es) 2008-08-13

Family

ID=38508902

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102453A AR061262A1 (es) 2006-06-07 2007-06-07 Metodo para tratar trastornos respiratorios uso de un antibiotico enla fabricacion de un aerosol y composicion de antibiotico en aerosol

Country Status (4)

Country Link
AR (1) AR061262A1 (es)
PE (1) PE20080329A1 (es)
TW (1) TW200815002A (es)
WO (1) WO2007145868A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102641249A (zh) * 2012-05-06 2012-08-22 江苏奥赛康药业股份有限公司 一种替加环素组合物的制备方法
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
US20220233555A1 (en) * 2019-05-24 2022-07-28 Stichting Radboud Universitair Medisch Centrum Improved administration of glycylcyclines by inhalation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5630409A (en) * 1995-03-22 1997-05-20 Bono; Michael Nebulizer and inhalation device containing same
GB0004531D0 (en) * 2000-02-25 2000-04-19 Richards Andrew J M The treatment of respiratory diseases
US7766013B2 (en) * 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
CA2477979A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for treatment of intracellular infections

Also Published As

Publication number Publication date
TW200815002A (en) 2008-04-01
PE20080329A1 (es) 2008-04-09
WO2007145868A1 (en) 2007-12-21

Similar Documents

Publication Publication Date Title
AR061262A1 (es) Metodo para tratar trastornos respiratorios uso de un antibiotico enla fabricacion de un aerosol y composicion de antibiotico en aerosol
CY1122807T1 (el) Συνθεσεις, μεθοδοι και συστηματα για τη χορηγηση δυο ή περισσοτερων δραστικων παραγοντων δια της αναπνευστικης οδου
NZ573555A (en) Nanoparticulate posaconazole formulations
CL2008001966A1 (es) Composicion de disolucion oral que comprende lamotrigina,en forma de particulas con lamotrigina recubiertas con una capa para enmascarar el sabor y granulos que comprenden un desinfectante y un alcohol de azucar y/o un hidrato de carbono; metodo de preparacion;uso para tratar trastornos del humor y prevencion de ataques.
CO2018011051A2 (es) Formas de dosificación de liberación modificada disuasivas de abuso
NO20092527L (no) Prolegemidler, fremgangsmate for fremstilling og anvendelse derav
AR053026A1 (es) Composiciones de anticuerpos anti factor de estimulacion de colonias de macrofagos (anti-m csf)
CL2018001420A1 (es) Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma. (divisional solicitud 201701853)
BRPI0806392A8 (pt) uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica
BRPI0603073A (pt) método para distribuição de fármacos para tecido sob propulsão de microjatos
AR058194A1 (es) Medicamentos que comprenden un agente antimuscarinico y un corticoesteroide
TW200642704A (en) Oral drug delivery system and methods of use thereof
CO6361899A2 (es) Pariculas inhalables que comprenden tiotropio
RS52867B (en) GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS
CL2013002033A1 (es) Preparacion oral de desintegracion rapida que comprende granulos que comprenden un medicamento, un agente de desintegracion, un aglutinador, un agente de enmascaramiento y un agente de solubilizacion; metodo de preparacion; su uso para la profilaxis y/o tratamiento de un padecimiento bipolar.
AR057904A1 (es) Medicamentos que comprenden un agente antimuscerinico y un corticoesteroide
MX2009000849A (es) Formas de dosificacion liofilizadasdisolvibles oralmente/desintegrables que contienen particulas protegidas.
ATE505203T1 (de) Pharmazeutische kombination aus aliskiren und valsartan
AR061263A1 (es) Metodo para tratar trastornos respiratorios
EA200802350A2 (ru) Система доставки лекарств
BR0312619A (pt) Composição farmacêutica, método para formular uma composição de modafinil, unidade de dosagem farmacêutica, e, métodos para alterar o estado sonolento de um mamìfero, intensificar a condição de atividade ou aumentar a regularidade da periodicidade do sono
BR112013029149A2 (pt) processo de produção de material inorgânico em partículas
CL2012001940A1 (es) Composiciones que comprenden extractos de andrographis paniculata combinados con extractos de ginkgo biloba complejados con fosfolípidos; y su uso en la preparación de un medicamento para el tratamiento de alzheimer y esclerosis múltiple.
BRPI0506630A (pt) composição de liberação controlada e método para administrar um medicamento aquoso transmucosal de liberação controlada
CR9200A (es) Uso de un agonista 5-ht6 para el tratamiento y la prevencion de trastornos neurodegenerativos

Legal Events

Date Code Title Description
FB Suspension of granting procedure